KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Debt Ratio (2016 - 2024)

Historic Debt Ratio for Biomarin Pharmaceutical (BMRN) over the last 15 years, with Q2 2024 value amounting to 0.07.

  • Biomarin Pharmaceutical's Debt Ratio changed N/A to 0.07 in Q2 2024 from the same period last year, while for Jun 2024 it was 0.07, marking a year-over-year change of. This contributed to the annual value of 0.07 for FY2023, which is 278979.29% up from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Debt Ratio stood at 0.07 for Q2 2024.
  • Over the past 5 years, Biomarin Pharmaceutical's Debt Ratio peaked at 0.08 during Q1 2020, and registered a low of 0.0 during Q4 2022.
  • In the last 5 years, Biomarin Pharmaceutical's Debt Ratio had a median value of 0.01 in 2022 and averaged 0.04.
  • In the last 5 years, Biomarin Pharmaceutical's Debt Ratio surged by 298955.01% in 2020 and then plummeted by 9315.06% in 2021.
  • Over the past 5 years, Biomarin Pharmaceutical's Debt Ratio (Quarter) stood at 0.06 in 2020, then plummeted by 86.78% to 0.01 in 2021, then plummeted by 68.9% to 0.0 in 2022, then soared by 2789.79% to 0.07 in 2023, then decreased by 3.0% to 0.07 in 2024.
  • Its Debt Ratio stands at 0.07 for Q2 2024, versus 0.07 for Q1 2024 and 0.07 for Q4 2023.